Personalised management of community-acquired pneumonia and the role of clinical decision support software
Hatton, Christopher Atkin, Catherine Gallier, Suzy Sapey, Elizabeth
Hatton, Christopher
Atkin, Catherine
Gallier, Suzy
Sapey, Elizabeth
Abstract
Community-acquired pneumonia (CAP) is one of the most common causes of hospital admission and is associated with significant morbidity and mortality. National and international guidelines are available to guide the management of CAP, including antibiotic prescribing. However, these guidelines are often not adhered to and there is significant overprescribing of broad-spectrum antibiotics, contributing to the growing pandemic of antimicrobial resistance. Clinical Decision Support Software (CDSS) are electronic tools that use individual patient data to generate patient specific assessments or recommendations, that can then be acted on by the patient or clinical decision maker. This article reviews the evidence surrounding the initial management of CAP in hospital and considers the potential of CDSS to support CAP management.
MIDER Authors
Affiliations
Department of Inflammation and Ageing, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK; NIHR Midlands Patient Safety Research Collaboration, University of Birmingham, Birmingham, England, UK; Department of Inflammation and Ageing, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK.; PIONEER Health Data Research Hub in Acute Care, Department of Research Development and Innovation, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Date
2026-04-15
Type
Article
Collections
Citation
Hatton C, Atkin C, Gallier S, Sapey E. Personalised management of community-acquired pneumonia and the role of Clinical Decision Support Software. BMJ Open Respir Res. 2026 Apr 15;13(1):e003096. doi: 10.1136/bmjresp-2024-003096.